Authors: Risbridger, GP Mellor, SL McPherson, SJ Schmitt, JF

Citation: Gp. Risbridger et al., The contribution of inhibins and activins to malignant prostate disease, MOL C ENDOC, 180(1-2), 2001, pp. 149-153

Authors: Cancilla, B Jarred, RA Wang, H Mellor, SL Cunha, GR Risbridger, GP

Citation: B. Cancilla et al., Regulation of prostate branching morphogenesis by activin A and follistatin, DEVELOP BIO, 237(1), 2001, pp. 145-158

Authors: Mellor, SL Cranfield, M Ries, R Pedersen, J Cancilla, B de Kretser, D Groome, NP Mason, AJ Risbridger, GP

Citation: Sl. Mellor et al., Localization of activin ss(A)-, ss(B)-, and ss(C)-subunits in human prostate and evidence for formation of new activin heterodimers of ss(C)-subunit, J CLIN END, 85(12), 2000, pp. 4851-4858

Authors: Mellor, SL Wellings, DA Fehrentz, JA Paris, M Martinez, J Ede, NJ Bray, AM Evans, DJ Bloomberg, GB

Citation: Sl. Mellor et al., Synthesis of modified peptides, PRACT APPR, 222, 2000, pp. 137-181

Authors: McPherson, SJ Mellor, SL Wang, H Evans, LW Groome, NP Risbridger, GP

Citation: Sj. Mcpherson et al., Expression of activin A and follistatin core proteins by human prostate tumor cell lines, ENDOCRINOL, 140(11), 1999, pp. 5303-5309